➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
Dow
Colorcon
AstraZeneca

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Pepcid Preservative Free In Plastic Container patents expire, and what generic alternatives are available?

Pepcid Preservative Free In Plastic Container is a drug marketed by Merck Sharp Dohme and is included in one NDA.

The generic ingredient in PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER is famotidine. There are eighteen drug master file entries for this compound. Ninety suppliers are listed for this compound. Additional details are available on the famotidine profile page.

US ANDA Litigation and Generic Entry Outlook for Pepcid Preservative Free In Plastic Container

A generic version of PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER was approved as famotidine by ATHENEX INC on April 16th, 2001.

  Start Trial

Summary for PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER
Drug patent expirations by year for PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER

US Patents and Regulatory Information for PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER famotidine INJECTABLE;INJECTION 020249-001 Feb 18, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
McKesson
Medtronic
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.